These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 776140)
41. [Role of beta-2-mimetic agents in the treatment of asthma]. Clauzel AM; Rifai N; Vergnaud A; Bony C; Michel FB Allerg Immunol (Paris); 1990 Nov; 22(9):377-82. PubMed ID: 1981829 [TBL] [Abstract][Full Text] [Related]
42. Bronchial challenge as an experimental model for evaluating anti-allergic drugs. Löwhagen O; Lindholm N Scand J Respir Dis Suppl; 1977; 101():43-7. PubMed ID: 343239 [No Abstract] [Full Text] [Related]
43. [A new bronchodilatador, hexoprenaline, in obstructive pulmonary disease (author's transl)]. van As A; Benjamin C; Stern JD Folia Clin Int (Barc); 1974 Jun; 24(6):485-97. PubMed ID: 4605471 [No Abstract] [Full Text] [Related]
44. [Bronchodilator effect of aerosol salbutamol in infantile bronchial asthma]. Miraglia del Giudice M; Tomasi L; Ferrara M Pediatria (Napoli); 1974 Mar; 82(1):48-64. PubMed ID: 4603371 [No Abstract] [Full Text] [Related]
45. Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol. Freedman BJ Br J Dis Chest; 1972 Jul; 66(3):222-9. PubMed ID: 4557902 [No Abstract] [Full Text] [Related]
46. Bronchodilator aerosols as maintenance therapy in asthma. What role now? Gilmartin JJ Ir Med J; 1993 Mar; 86(2):44. PubMed ID: 8386145 [No Abstract] [Full Text] [Related]
48. The effect of orciprenaline and its p-hydroxyphenyl derivative on the peak expiratory flow rate in asthmatic patients. Mattila MJ; Muittari A; Tiitinen H Arzneimittelforschung; 1967 Mar; 17(3):362-4. PubMed ID: 4869818 [No Abstract] [Full Text] [Related]
49. Delivery systems in the management of childhood asthma. Sly PD Aust Fam Physician; 1991 Aug; 20(8):1113-4, 1116-8. PubMed ID: 1953452 [TBL] [Abstract][Full Text] [Related]
50. [Letter: Study of the delay of action of an injected corticoid on bronchial obstruction in asthmatics. Comparison with an inhaled beta-stimulating agent]. Arnaud A; Orehek J; Autran P; Tricard P; Charpin J Nouv Presse Med; 1975 Apr; 4(16):1211. PubMed ID: 1099541 [No Abstract] [Full Text] [Related]
51. [Clinical evaluation of a new bronchodilator (terbutaline sulfate) in bronchial asthma]. Iida T; Satake T; Ishikawa Y; Ryuge K; Hara M Arerugi; 1972 Mar; 21(3):268-80. PubMed ID: 4557859 [No Abstract] [Full Text] [Related]
52. [Treatment of bronchial asthma in childhood using disodium cromoglycate]. Schmidt E; Pfingsten S Z Allgemeinmed; 1973 May; 49(14):686-90. PubMed ID: 4201929 [No Abstract] [Full Text] [Related]
53. Clinical trial of a new bronchodilator formulation. Br J Clin Pract; 1966 Nov; 20(11):569-71. PubMed ID: 5342073 [No Abstract] [Full Text] [Related]
54. Fixed dose combination therapy in asthma. The positive case for future therapy. Ruffin RE Prog Clin Biol Res; 1988; 263():427-35. PubMed ID: 2898154 [No Abstract] [Full Text] [Related]
55. Effect of cromolyn sodium on childhood asthma. Hyde JS; Buranakul B; Vithayasai V Ann Allergy; 1970 Oct; 28(10):449-58. PubMed ID: 4398782 [No Abstract] [Full Text] [Related]
56. [Bronchodilator therapy in patients with bronchial asthma]. Daniliak IG Klin Med (Mosk); 1990 Nov; 68(11):23-6. PubMed ID: 2283803 [No Abstract] [Full Text] [Related]
57. Stepwise therapy of bronchial asthma: the role of beta-adrenergic agonists. Nelson HS Ann Allergy; 1985 Apr; 54(4):289-93. PubMed ID: 2858995 [No Abstract] [Full Text] [Related]
58. Non-prescription use of bronchodilator aerosols. Curran MA Med J Aust; 1992 May; 156(10):742. PubMed ID: 1620028 [No Abstract] [Full Text] [Related]
60. [Critical evaluation of a long acting bronchodilator agent in the treatment of asthma and chronic bronchial diseases]. Paramelle F; Paramelle B Therapeutique; 1973 Nov; 49(9):591-4. PubMed ID: 4600038 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]